Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent

類似資料

• Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection
  著者:: Colley, Thomas, 等
  出版事項: (2019)
• In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice
  著者:: Kimura, Genki, 等
  出版事項: (2017)
• In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris
  著者:: Rudramurthy, Shivaprakash M, 等
  出版事項: (2019)
• 1335. Safety and Pharmacokinetic Profile of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-protein Polymerase, in a Single and Multiple-Ascending Dose Study in Healthy Volunteer and Mild Asthmatics
  著者:: Cass, Lindsey, 等
  出版事項: (2018)
• PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
  著者:: Murray, Alison, 等
  出版事項: (2020)